15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 0.7% per year over the past 5 years.
Operating margin has contracted, at -2.7% in the latest year.
Free cash flow has declined 22.1% per year over the past 5 years.
Financial health
Total debt ($9.4B) exceeds cash ($2.0B); net debt is $7.5B.
Total debt has grown faster than revenue (8.7% vs -0.7% per year).
Operating income covered interest expense -1.1× in the latest year, down from 11× 5 years ago.
Total debt is 14× EBITDA.
Shareholder returns
Dividends have been paid for 15 consecutive years, consuming 104.8% of free cash flow.
The dividend has declined 6.0% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$11.2B
-$957M
30.1%
-2.7%
-15.6%
-4.8%
$332M
$9.4B
$2.0B
2024
$10.6B
-$649M
37.5%
0.1%
-9.3%
-2.5%
$573M
$15.3B
$1.8B
2023
$10.4B
$2.7B
40.1%
6.8%
31.6%
9.4%
$1.3B
$13.9B
$3.1B
2022
$10.1B
-$2.4B
35.3%
-28.3%
-41.7%
-8.6%
$834M
$17.0B
$1.6B
2021
$12.1B
$1.3B
38.9%
11.1%
14.1%
3.8%
$1.5B
$18.1B
$3.0B
2020
$11.7B
$1.1B
39.3%
13.8%
12.7%
5.5%
$1.2B
$6.2B
$3.7B
2019
$11.4B
$1.0B
41.9%
15.6%
12.7%
5.5%
$1.4B
—
$3.3B
2018
$11.1B
$1.5B
42.9%
14.3%
19.7%
9.8%
$1.4B
—
$1.8B
2017
$10.6B
$602M
42.3%
12.2%
6.6%
3.5%
$1.1B
—
$3.4B
2016
$10.2B
$5.0B
40.5%
7.3%
59.9%
31.9%
$935M
—
$2.8B
2015
—
$968M
—
—
10.9%
4.6%
$860M
—
$2.2B
2014
—
$2.5B
—
—
30.8%
9.6%
$2.3B
—
$2.9B
2013
—
$2.0B
—
—
23.8%
8.0%
$2.5B
—
$2.7B
2012
—
$2.3B
—
—
33.5%
11.4%
$1.9B
—
$3.3B
2011
—
$2.2B
—
—
33.8%
11.7%
$1.9B
—
$2.9B
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$3.0B
$126M
34.9%
7.3%
2.0%
0.6%
—
—
$2.1B
Mar '26
$2.7B
-$15M
33.0%
2.4%
-0.2%
-0.1%
—
—
$2.0B
Dec '25
$3.0B
-$1.1B
19.4%
-24.5%
-18.4%
-5.6%
—
$9.4B
$2.0B
Sep '25
$2.8B
-$46M
33.5%
6.1%
-0.6%
-0.2%
—
—
$1.7B
Jun '25
$2.8B
$91M
35.3%
6.8%
1.2%
0.4%
—
—
$1.7B
Mar '25
$2.6B
$126M
32.8%
2.2%
1.8%
0.6%
—
—
$2.3B
Dec '24
$2.8B
-$512M
34.8%
-15.8%
-7.4%
-2.0%
—
$15.3B
$1.8B
Sep '24
$2.7B
$140M
38.3%
5.7%
1.8%
0.5%
—
—
$1.4B
Jun '24
$2.7B
-$314M
38.3%
6.6%
-4.1%
-1.2%
—
—
$1.6B
Mar '24
$2.5B
$37M
38.6%
4.6%
0.5%
0.1%
—
—
$2.8B
Dec '23
$2.7B
$245M
40.3%
11.1%
2.9%
0.9%
$341M
$13.9B
$3.1B
Sep '23
$2.6B
$2.5B
40.6%
6.9%
31.0%
8.2%
$191M
—
$5.7B
Jun '23
$2.6B
-$141M
39.8%
-0.7%
-2.5%
-0.5%
$195M
—
$1.7B
Mar '23
$3.5B
$44M
36.3%
3.7%
0.7%
0.2%
$307M
—
$1.7B
Dec '22
$3.7B
$181M
37.1%
7.7%
3.1%
0.6%
$257M
$17.0B
$1.6B
Sep '22
$3.6B
-$2.9B
29.0%
-79.8%
-53.1%
-10.5%
$129M
—
$1.6B
Jun '22
$3.6B
$252M
38.1%
7.3%
2.8%
0.8%
$137M
—
$1.9B
Mar '22
$3.7B
$71M
36.4%
4.4%
0.8%
0.2%
$68M
—
$2.3B
Dec '21
$3.5B
$238M
40.0%
10.9%
2.6%
0.7%
$458M
$18.1B
$3.0B
Sep '21
$3.2B
$450M
40.9%
15.9%
5.1%
2.3%
$496M
—
$3.3B
Valuation over time
How the market has priced BAX against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 7.5× (Jan '24) to 6.6× (Nov '24).
The price-to-sales ratio has fallen from 2.1× (Mar '23) to 1.2× (Sep '26).
The dividend yield has fallen from 2.7% (Mar '23) to 2.6% (Sep '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is BAX growing its revenue and profit?
Over the past 5 years, Baxter International's revenue has declined 0.7% per year. These are computed facts, not advice.
How much debt does BAX have?
As of FY2025, Baxter International reported $9.4B of total debt against $2.0B of cash; operating income covered interest expense -1.1×.
What is BAX's profit margin?
In FY2025, gross margin was 30.1%, operating margin -2.7%, and net margin -8.5%.
What is BAX's P/E ratio?
As of Sep '26, Baxter International traded at a price-to-earnings ratio of about 6.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.